Third-generation cephalosporin resistant Escherichia coli in dogs and cats in Germany in 2019–2021

  28 August 2024

This research aimed to determine the 3rd generation cephalosporin resistance (3GCR) in Escherichia coli isolated from clinical samples of dogs and cats in Germany. The study used data from antimicrobial susceptibility testing (AST) from 3,491 veterinary practices in Germany from 2019 to 2021. Out of 175,171 clinical samples, 14,6% were evaluated for susceptibility to antimicrobials, including cefovecin. The cefovecin resistance proportion was 11.6%, with local variations of ±3%. The study highlights the importance of integrated AMR monitoring and the potential transmission of 3GCR between companion animals and other environmental sources.

Further reading: PLOS One
Author(s): Stefanie Katharina Frenzer et al
Healthy Animals  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed